大动脉置换后的血糖控制:一项回顾性研究
Yuval Avidan1, Amir Aker1, Ibrahim Naoum1
1Department of Cardiology, Lady Davis Carmel Medical Center, Haifa, Israel.
International journal of cardiology. Heart & vasculature
|January 24, 2025
概括
大动脉置换 (AVR) 改善了糖尿病患者的血糖控制. 超导管大动脉植入 (TAVI) 与手术大动脉置换 (SAVR) 相比,显示出更大的改善趋势.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 炎症研究 炎症研究
背景情况:
- 大动脉狭窄 (AS) 是一种常见的病症,可以通过透气管大动脉植入 (TAVI) 或手术大动脉置换 (SAVR) 来治疗.
- 糖尿病在接受主动脉置换 (AVR) 的患者中非常普遍.
- 炎症在AS病变发生中起作用,TAVI可能具有抗炎性质,这表明它可能对糖尿病患者的血糖控制产生潜在影响.
研究的目的:
- 研究大动脉置换 (AVR) 对糖尿病患者血糖控制的影响.
- 为了比较TAVI与SAVR对糖化血红蛋白 (HbA1c) 水平的影响.
主要方法:
- 从2010年1月至2022年1月接受TAVI或SAVR治疗的10,129名患者的回顾性分析.
- 专注于1284名糖尿病患者和手术前和后的HbA1c测量 (HbA1c≥7%).
- 倾向性得分匹配为分析创造了266名TAVI和266名SAVR患者的可比队列.
主要成果:
- 在1284名患者的队列中,总体HbA1c显著下降,从8.15%降至7.88% (p < 0.001).
- 在匹配的队列中,TAVI患者的HbA1c显著减少,从8.31%降至7.86% (p < 0.001).
- SAVR患者的HbA1c从8.33%降低到8.15% (p = 0.046),而TAVI显示出更大的改善趋势 (p = 0.051).
结论:
- 无论是TAVI还是SAVR,都能改善AVR的未控制糖尿病患者的血糖控制.
- 血糖指数的改善在TAVI组中显得更加明显.
- 需要进一步的前性研究来证实这些发现并阐明涉及的机制.
更多相关视频
相关概念视频
Assessing Blood pressure in the Leg
18.1K
Proper measurement of leg blood pressure is a critical skill for healthcare providers, ensuring precise and reliable readings. When performed correctly, this procedure informs patient care and enhances the efficacy of interventions. The following text outlines step-by-step guidelines to measure blood pressure in the leg, providing clarity and ease of understanding for practitioners.
Preparation:
Preparation:
18.1K
Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Hypertension III: Clinical Manifestations and Diagnostic Studies
891
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
891
Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36
Complications of Diabetes Mellitus
43
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
43


